0001615192-19-000008.txt : 20190611
0001615192-19-000008.hdr.sgml : 20190611
20190611162400
ACCESSION NUMBER: 0001615192-19-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190610
FILED AS OF DATE: 20190611
DATE AS OF CHANGE: 20190611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGrody Kevin J
CENTRAL INDEX KEY: 0001615192
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 19891271
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-06-10
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001615192
McGrody Kevin J
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Controller
Common Stock
2019-06-10
4
X
0
3805
58.79
A
7574
D
Common Stock
2019-06-10
4
X
0
438
61.76
A
8012
D
Common Stock
2019-06-10
4
S
0
3019
231.37
D
4993
D
Common Stock
2019-06-10
4
S
0
82
231.95
D
4911
D
Common Stock
2019-06-10
4
S
0
4243
231.89
D
668
D
Non-Qualified Stock Option (right to buy)
58.79
2019-06-10
4
X
0
3805
58.79
D
2024-02-24
Common Stock
3805
0
D
Non-Qualified Stock Option (right to buy)
61.76
2019-06-10
4
X
0
438
61.76
D
2023-02-06
Common Stock
438
0
D
These securities are vested Restricted Stock Units.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $231.23 to $231.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares were previously acquired through the Registrant's Employee Stock Purchase Plan.
All shares sold were sold at the exact price disclosed.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
By: Alejandro Parras, Attorney-In-Fact For: Kevin J. McGrody
2019-06-11